Artificial Intelligence (AI) in Pharmaceutical Market Size Worth USD 28.63 Billion By 2034| CAGR: 31.2%
The global artificial intelligence (AI) in pharmaceutical market size is expected to reach USD 28.63 billion by 2034, according to a new study by Polaris Market Research. The report “Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends, Industry Analysis Report: By Technology, By Offering, By Deployment (Cloud and On-Premises), By Application, By End Use, and By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising funding and investment in R&D activities by private and public players in the pharma industry are driving the market's growth. As funding in the industry rises, major players' adoption of artificial intelligence in pharmaceuticals also increases to ease the process. Further, the growing importance of precision medicine and increased investment in R&D for the use of artificial intelligence technology in this industry are expected to contribute to industry expansion.
The introduction of artificial intelligence in the pharma sector results from increasing demand on drugmakers to reduce drug prices. Reduced clinical trial failure rates while simultaneously eliminating the cost of long-term drug discovery and development. Various pharma companies have already developed wearables that use artificial intelligence algorithms to remotely monitor patients with life-threatening conditions.
AI in Pharmaceutical Market Report Highlights
- The natural language processing segment dominated the market with 35.64% revenue share in 2025. This is because NLP in healthcare and life sciences allows easier translation of data into a narrative form.
- The cloud segment led the market in 2025. The cloud model takes away the large upfront investments associated with on-premise deployment by providing AI services on a pay-per-use basis.
- North America accounted for the largest market share in 2025. This is due to the presence of leading pharmaceutical companies and healthcare infrastructure in this region.
- Asia Pacific is projected to experience the fastest growth during this forecast period. The regional market is driven by the rapid growth of biotechnology research and healthcare investments.
- Some of the major players operating in the global AI in pharmaceutical market include AstraZeneca LLC, Atomwise Inc., Bayer AG, Cloud Pharmaceuticals Inc, GNS Healthcare, IBM Watson, Merck & Co., Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer Inc., Recursion Pharmaceuticals Inc., and XtalPi Inc.
Where is the Market Headed?
The AI in pharmaceutical market is expected to grow rapidly as more companies are using AI for the development of research drugs. AI is helpful in the development of drugs and the prediction of outcomes. With the increasing demand for the development of research drugs and the improvement of healthcare services, AI in the pharmaceutical industry is expected to grow steadily.
What Does AI in Pharmaceutical Report Reveal?
- What is the global market size and CAGR for the market during 2026–2034?
- Which factors are contributing to the industry expansion?
- Who are the key industry players? What is their relative position in terms of competitive positioning?
- How do different technologies, such as machine learning and natural language processing, influence the market landscape?
- How does the market differ in terms of technology, offering, deployment, application, end user, and geography? Which is the leading end user?
- What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- What are the emerging technologies and innovations in the market?
Request a free sample copy or read the full market insights : Artificial Intelligence (AI) in Pharmaceutical Market Report
Polaris Market Research has segmented the artificial intelligence in pharmaceutical market report based on technology, offering, deployment, application, end user, and region:
By Technology Outlook (Revenue, USD Billion, 2021–2034)
- Machine Learning
- Natural Language Processing
- Deep Learning
- Others
By Offering Outlook (Revenue, USD Billion, 2021–2034)
- Hardware
- Software
- Services
By Deployment Outlook (Revenue, USD Billion, 2021–2034)
- Cloud
- On-Premises
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Drug Discovery
- Precision Medicine
- Medical Imaging & Diagnostics
- Research
By End User Outlook (Revenue, USD Billion, 2021–2034)
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostic Centers
- Academic & Research Institutes
- Others
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
